pH7

01. About Lilly
Lilly UK

Lilly is one of the world's leading innovative pharmaceutical companies. Lilly's research centre in the UK received the Queen's Award for Innovation in 2000 for the discovery of the atypical antipsychotic Zyprexa (olanzapine). In comparison to other atypical antipsychotics, Zyprexa was recently quoted as being the "market leader in value terms"1. 1 Scrip, March 6, 2002.

STOP PRESS: It has just been announced that Lilly UK has been selected as one of the 100 best companies to work for in the UK by the Sunday Times. The 100 companies were chosen as a result of research conducted by the "Great Place to Work Trust", an independent research firm. The project was supported and part-funded by the Department of Trade and Industry.


 
pH7
Also in this issue:
01. About Lilly

Lilly UK

02. Introductin to Special Focus

pH7 - Special Focus on Schizophrenia

03. Britain: the stressed man of Europe?

Dr Ian Gibson MP analyses theresults of an exclusive pH7 / Harris Poll of Members of Parliament on mental health

04. The great leap forward

The inclusion of mental health in the NHS Plan is a fantastic step forward which will revolutionise how services are delivered, says Louis Appleby

05. Out of sight, out of mind

No-one paid attention to Christopher Clunis until he murdered Jayne Zito's husband. Sally Dawson reports

06. The Cinderella Service

The government is simply failing to deliver on its mental health promises, says Oliver Heald MP, and sufferers remain forgotten

07. Eyes wide shut

When it comes to mental health, people still turn their heads away, says Sandra Gidley MP

08. Rhetoric and reality

People need recognition of their individuality not one-for-all placements, writes Marjorie Wallace

09. Shrink-wrapped services

The image of psychiatry is all too often one of protocol bound inflexibility, writes Dr Martin Deahl

10. Severe mental illness: time for a rethink

We need to challenge ourselves and our approaches if we are to overcome stigma and break down barriers so people can access the best treatment available, writes Cliff Prior

11. Medication: a question of choice?

For Tim Newey, being prescribed the right type of medication was the equivalent of a rope being thrown to him in a 'very dark place'. So, he writes, when it comes to quality of care for mental health patients, you get what you pay for

12. Ending the stigma

If there was no shame attached to a visit to a psychiatrist then people would be more likely to seek help when they need it, writes Lynne Jones MP

13. Re-engaging the world

Sally Dawson reviews A Beautiful Mind

14. Postcards from the front line

Sally Dawson reports how Dr David Pelta and his team have transformed the delivery of community-based mental health services

15. Financing new drugs in the NHS

Dr Roger Bullock shares his experience of the challenge of getting appropriate care to patients

16. Labour mental health policy: coercive or creative?

So often for the mentally ill, second best - it seems - is good enough, says Professor Ray Rowden

Rethink